CO167 Evaluating Risk of Progression with Selumetinib in Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma: Propensity Score Method (PSM) Analysis of the Sprint Trial Vs a Natural History (NH) Control Arm
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2303
https://www.valueinhealthjournal.com/article/S1098-3015(23)02403-8/fulltext
Title :
CO167 Evaluating Risk of Progression with Selumetinib in Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma: Propensity Score Method (PSM) Analysis of the Sprint Trial Vs a Natural History (NH) Control Arm
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02403-8&doi=10.1016/j.jval.2023.03.2303
First page :
Section Title :
Open access? :
No
Section Order :
11630